Delivery Order SPE2DR25D3004-SPE2DR26FXRF0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5 milliliter units, with a ceiling value of $1,650.30 and an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government and will be performed at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,096.94 to AmerisourceBergen Drug Corp for Loteprednol Etabonate 0.5% ophthalmic drops (5 mL) on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,842.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5 mL quantities. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is non-competitive and scheduled for completion by August 1, 2025. Performance will be fulfilled...
- The Defense Logistics Agency awarded a delivery order valued at $1,886.24 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5ML quantities. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 22, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in a 5 mL unit, with a ceiling value of $1,267.04. This competitive award utilizes a firm fixed price structure and is classified as a child contract under a larger vehicle. The performance location is identified as Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. No set-aside designation was applied...
- The Defense Logistics Agency awarded a $1,092.99 delivery order to AmerisourceBergen Drug Corp for Loteprednol Etabonate 0.2% ophthalmic drops (5 mL) on October 31, 2025, with completion targeted for November 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, fulfills...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,240.45 firm fixed-price contract is for the delivery of Loteprednol Etabonate 0.5% ophthalmic drops. The order has a completion date of June 23, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of a pharmaceutical product, loteprednol etabonate 0.2% eye drops, with a ceiling value of $3,286.90 and a period of performance through April 5, 2024. The contract is a firm fixed price delivery order with no set-aside...
- This federal contract award, valued at $1,097.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LOTEPREDNOL ETABONATE 0.2% DRP 5ML, a pharmaceutical eye drop product. The contract has an ultimate completion date of December 24, 2024 and is a firm fixed-price contract. AmerisourceBergen, a for-profit organization, is the prime contractor,...
- This delivery order, valued at $2,630.16, was awarded on August 19, 2025, to AmerisourceBergen Drug Corp for the supply of Loteprednol Etabonate 0.5% ophthalmic suspension. The contract is a firm fixed-price delivery order issued under the Defense Logistics Agency's Medical Supply Chain program, with performance to be completed by August 19, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made on a competitive, non-set-aside basis, consistent with the...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXRF0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Loteprednol Etabonate 0.2% eye drops (5mL) with a ceiling value of $1,743.19 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 22, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate office and serves as a critical pharmaceutical distributor for federal medical procurement needs. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle provides comprehensive pharmaceutical support and enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. The company's federal contract portfolio demonstrates extensive experience fulfilling DLA medical supply requirements across multiple therapeutic domains, positioning it as a key vendor for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/18/25 |